NKTR
NASDAQ · Pharmaceuticals
Nektar Therapeutics
$72.22
-2.62 (-3.50%)
Open$74.90
Previous Close$74.84
Day High$75.48
Day Low$70.78
52W High$75.67
52W Low$6.48
Volume—
Avg Volume1.14M
Market Cap1.98B
P/E Ratio—
EPS$-7.58
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-41.5% upside
Current
$72.22
$72.22
Target
$42.23
$42.23
$31.85
$42.23 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 198.75M | 201.06M | 246.52M |
| Net Income | -240,216,024 | -218,709,581 | 56.66M |
| Profit Margin | -120.9% | -114.8% | 23.0% |
| EBITDA | -204,346,275 | -196,387,416 | 106.98M |
| Free Cash Flow | — | — | 45.61M |
| Rev Growth | -1.2% | -1.2% | +15.2% |
| Debt/Equity | 1.51 | 1.51 | 0.88 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |